To know more about Retinopathy of Prematurity, please click here.

Migrated AMSCs in retina

Amniotic membrane derived stem cell transplants show benefit in retinal diseases

A team of researchers at the CHA University in South Korea has successfully transplanted mesenchymal stromal cells (MSCs) derived from human amniotic membranes of the placenta (AMSCs) into laboratory mice modeled with oxygen-induced retinopathy, which is used to simulate many retinal diseases. The treatment aimed at suppressing abnormal angiogenesis (blood vessel growth) which is recognized

READ MORE…

Indirect laser treatment

Belize July 2015

This trip was supported by Allergan Foundation, with instrument support from IRIDEX. Our CEO Dr Raj Agrawal made his second trip to Belize recently. This time, apart from seeing patients in Belize City, he also traveled to Orange Walk, which is an hour’s drive away from Belize City, as well as to Dangriga, which is

READ MORE…

Visit to Belize

This project has been made possible by a grant from Allergan Foundation. Driving to BCVI’s National Eye Clinic BCVI’s National Eye Clinic BCVI’s National Eye Clinic Belize City Pouring rain in Belize City An ROP baby being examined in the clinic Discussing the outcomes of the exam with the mother Discussing the outcomes of the

READ MORE…

Telemedicine of ROP babies makes for early diagnosis and treatment

Retinopathy of prematurity (ROP) continues to be an ongoing challenge for both ophthalmologists and neonatologists and remains a significant threat to vision for extremely premature infants despite the availability of therapeutic modalities. It remains a leading cause of morbidity despite, (and interestingly) as well as because of, advances in neonatal care, which have improved survival

READ MORE…